LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $180,125,000 | +11.4% | 1,772,705 | +11.9% | 0.03% | 0.0% |
Q3 2016 | $161,744,000 | -7.5% | 1,584,794 | +8.1% | 0.03% | -15.4% |
Q2 2016 | $174,906,000 | +18.6% | 1,466,467 | +6.5% | 0.04% | +14.7% |
Q1 2016 | $147,463,000 | +0.5% | 1,377,004 | +1.8% | 0.03% | 0.0% |
Q4 2015 | $146,696,000 | +26.6% | 1,353,035 | +0.0% | 0.03% | +13.3% |
Q3 2015 | $115,844,000 | -10.2% | 1,352,528 | +5.8% | 0.03% | -3.2% |
Q2 2015 | $128,938,000 | +25.4% | 1,277,878 | -4.1% | 0.03% | +24.0% |
Q1 2015 | $102,788,000 | +51.3% | 1,333,008 | +4.4% | 0.02% | +47.1% |
Q4 2014 | $67,951,000 | +16.6% | 1,277,041 | +2.9% | 0.02% | +6.2% |
Q3 2014 | $58,298,000 | -27.9% | 1,240,648 | -4.5% | 0.02% | -30.4% |
Q2 2014 | $80,909,000 | -11.2% | 1,298,901 | -4.1% | 0.02% | -14.8% |
Q1 2014 | $91,151,000 | +31.5% | 1,355,000 | +2.8% | 0.03% | +28.6% |
Q4 2013 | $69,336,000 | +120.8% | 1,318,179 | +81.7% | 0.02% | +90.9% |
Q3 2013 | $31,396,000 | +32.8% | 725,419 | +14.8% | 0.01% | +22.2% |
Q2 2013 | $23,636,000 | – | 631,980 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |